Tag: Incyte

As pharmaceutical companies compete to develop the next generation of breakthrough treatments, Incyte appears to be positioning a potentially significant ...

As the patent protection for its blockbuster drug Jakafi approaches expiration, biopharmaceutical firm Incyte is implementing a two-pronged strategy to ...

Biopharmaceutical company Incyte may be on the verge of a significant advancement for its dermatology division. New long-term results for ...

The investment community is closely monitoring Incyte Corporation as a significant regulatory milestone approaches. A forthcoming decision by the U.S. ...

A notable divergence has emerged in the trading activity surrounding biotech firm Incyte. The stock is climbing toward new peaks, ...

The biotechnology sector has found a standout performer in Incyte Corporation. While numerous competitors grapple for incremental growth, this company ...

The biotechnology sector remains a dynamic arena where groundbreaking research achievements often collide with disappointing setbacks. Incyte Corporation finds itself ...

A significant shift in institutional ownership is underway for biotech firm Incyte, with major funds and asset managers substantially increasing ...